Coronavirus: Health ministry restricts sale, distribution of hydroxychloroquine

By: |
Published: March 27, 2020 11:49 AM

The order issued on Thursday said that in public interest, it was necessary and expedient to regulate and restrict the sale and distribution of the drug and preparation based thereon for preventing misuse.

Coronavirus, Coronavirus pandemic, health ministry, COVID-19 pandemic, hydroxychloroquine, hydroxychloroquine for coronavirusThe treatment protocol recommended by the ICMR has been approved by the Drug Controller General of India (DGCI) for restricted use in emergency situations. (Representational image)

The Union health ministry has restricted the sale and distribution of ‘hydroxychloroquine’ stating it as an essential drug to meet the requirements of any emergency arising due to COVID-19 pandemic. The order issued on Thursday said that in public interest, it was necessary and expedient to regulate and restrict the sale and distribution of the drug and preparation based thereon for preventing misuse.

“The Central government is satisfied that the drug ‘hydroxychloroquine’ is essential to meet the requirements of emergency arising due to pandemic COVID-19 and in the public interest, it is necessary and expedient to regulate and restrict the sale and distribution of the drug and preparation based thereon for preventing their misuse,” it said.

“Now, therefore, in exercise of the powers conferred by Section 26B of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government hereby directs that sale by retail of any preparation containing the drug hydroxychloroquine shall be in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules, 1945,” it stated. This order shall come into force on the date of its publication in the official gazette.

ICMR has recommended the use of hydroxychloroquine as a preventive medication for healthcare workers involved in the care of suspected or confirmed cases of COVID-19 and also asymptomatic household contacts of laboratory confirmed cases. The treatment protocol recommended by the ICMR has been approved by the Drug Controller General of India (DGCI) for restricted use in emergency situations.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 vaccine: Expert Group plans to ready digital platform to track procurement, storage, delivery of vaccine
2Record single-day spike of 66,999 cases pushes India’s COVID-19 tally to 23,96,637; death toll 47,033
3Conflict actors exploiting current uncertain climate through misinformation: India at UN